(Q28142535)

English

Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma

scientific article (publication date: August 1999)

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma (English)

0 references

author name string

M J Tafreshi

series ordinal

1

0 references

A B Weinacker

series ordinal

2

0 references

language of work or name

English

0 references

publication date

August 1999

0 references

published in

Pharmacotherapy

0 references

volume

19

0 references

issue

8

0 references

page(s)

974-8

0 references

cites work

Beta-blockers and asthma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Effect in bronchial asthma of a new beta-adrenergic blocking drug atenolol (ICI 66, 082)

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction: National Cooperative Cardiovascular Project.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Comparative study of the ventilatory effects of three beta 1-selective blocking agents in asthmatic patients

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Asthma and beta-blockers

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Letter from westminster

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Near-fatal bronchospasm after oral nadolol in a young asthmatic and response to ventilation with halothane.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Beta-adrenergic blockers, immunotherapy, and skin testing. American Academy of Allergy and Immunology

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1592%2FPHCO.19.11.974.31575

retrieved

21 January 2018

Identifiers

DOI

10.1592/PHCO.19.11.974.31575

0 references

PubMed publication ID

10453968

0 references

(Q28142535)

Beta-adrenergic-blocking agents in bronchospastic diseases: a therapeutic dilemma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)